ImmuneOnco Biopharmaceuticals (Shanghai) Inc

HKSE:01541 (China)   Ordinary Shares - Class H
HK$ 5.11 (+0.59%) Dec 24
At Loss
P/B:
2.96
Market Cap:
HK$ 2.09B ($ 267.96M)
Enterprise V:
HK$ 1.63B ($ 209.88M)
Volume:
6.69M
Avg Vol (2M):
13.84M
Trade In:
Volume:
6.69M
At Loss
Avg Vol (2M):
13.84M

Business Description

Description
ImmuneOnco Biopharmaceuticals (Shanghai) Inc is a science-driven biotechnology company dedicated to the development of immuno-oncology therapies. It is one of the few biotechnology companies globally adopting a systematic approach to harness both the innate and adaptive immune systems. It has developed a rich pipeline of 14 drug candidates with eight ongoing clinical programs, featured by a comprehensive innate-immunity-based asset portfolio. Its pipeline reflects its extensive understanding of the frontiers of cancer biology and immunology and its expertise in turning scientific research into drug candidates.
Name Current Vs Industry Vs History
Cash-To-Debt 5.25
Equity-to-Asset 0.81
Debt-to-Equity 0.16
Debt-to-EBITDA -0.27
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 7.26
Distress
Grey
Safe
Beneish M-Score -2.74
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 24.03
9-Day RSI 30.78
14-Day RSI 36.12
6-1 Month Momentum % -47.86
12-1 Month Momentum % -75.34

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 4.86
Quick Ratio 4.86
Cash Ratio 4.28
Days Sales Outstanding 28.54

Dividend & Buy Back

Name Current Vs Industry Vs History
Shareholder Yield % -3.01

Financials

HKSE:01541's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

ImmuneOnco Biopharmaceuticals (Shanghai) Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil HK$) 0.422
EPS (TTM) (HK$) -1.084
Beta 0
Volatility % 45.96
14-Day RSI 36.12
14-Day ATR (HK$) 0.574778
20-Day SMA (HK$) 5.888
12-1 Month Momentum % -75.34
52-Week Range (HK$) 3.21 - 30.45
Shares Outstanding (Mil) 407.31

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

ImmuneOnco Biopharmaceuticals (Shanghai) Inc Filings

Filing Date Document Date Form
No Filing Data

ImmuneOnco Biopharmaceuticals (Shanghai) Inc Stock Events

Financials Calendars
Event Date Price(HK$)
No Event Data

ImmuneOnco Biopharmaceuticals (Shanghai) Inc Frequently Asked Questions

What is ImmuneOnco Biopharmaceuticals (Shanghai) Inc(HKSE:01541)'s stock price today?
The current price of HKSE:01541 is HK$5.11. The 52 week high of HKSE:01541 is HK$30.45 and 52 week low is HK$3.21.
When is next earnings date of ImmuneOnco Biopharmaceuticals (Shanghai) Inc(HKSE:01541)?
The next earnings date of ImmuneOnco Biopharmaceuticals (Shanghai) Inc(HKSE:01541) is .
Does ImmuneOnco Biopharmaceuticals (Shanghai) Inc(HKSE:01541) pay dividends? If so, how much?
ImmuneOnco Biopharmaceuticals (Shanghai) Inc(HKSE:01541) does not pay dividend.

Press Release

Subject Date
No Press Release